195 related articles for article (PubMed ID: 17454859)
21. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.
Ferrari FS; Stella A; Gambacorta D; Magnolfi F; Fantozzi F; Pasquinucci P; Civeli L; Pieraccini M
Radiol Med; 2004 Oct; 108(4):356-71. PubMed ID: 15525889
[TBL] [Abstract][Full Text] [Related]
22. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
23. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model.
Orlando A; D'Antoni A; Cammà C; Albanese M; Livraghi T; Torzilli G; Virdone R; Sciarrino E; Simonetti RG; Maringhini A; Pagliaro L; Cottone M
Am J Gastroenterol; 2000 Oct; 95(10):2921-7. PubMed ID: 11051369
[TBL] [Abstract][Full Text] [Related]
24. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
25. Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
Seo DD; Lee HC; Jang MK; Min HJ; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ; Ko GY; Lee YJ; Lee SG
Ann Surg Oncol; 2007 Dec; 14(12):3501-9. PubMed ID: 17899289
[TBL] [Abstract][Full Text] [Related]
26. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma].
Tateishi H; Hasuike Y; Kinuta M; Furukawa J; Takata N; Maruyama H; Oi H; Yayoi E; Okamura J
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903
[TBL] [Abstract][Full Text] [Related]
27. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
[TBL] [Abstract][Full Text] [Related]
28. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
Horigome H; Nomura T; Saso K; Itoh M
Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
[TBL] [Abstract][Full Text] [Related]
29. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
30. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.
Cabibbo G; Genco C; Di Marco V; Barbara M; Enea M; Parisi P; Brancatelli G; Romano P; Craxì A; Cammà C
Aliment Pharmacol Ther; 2011 Jul; 34(2):196-204. PubMed ID: 21564144
[TBL] [Abstract][Full Text] [Related]
31. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
32. [Advanced hepatocellular carcinoma: therapeutic results in 110 patients and therapeutic strategy].
Inoue Y; Ishida T; Murakami T; Nakamura H
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1857-64. PubMed ID: 9797808
[TBL] [Abstract][Full Text] [Related]
33. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.
Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1177-83. PubMed ID: 16901768
[TBL] [Abstract][Full Text] [Related]
34. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
35. Median survival time of patients after transcatheter chemo-embolization for hepatocellular carcinoma.
Haider Z; ul Haq T; Munir K; Usman MU; Azeemuddin M
J Coll Physicians Surg Pak; 2006 Apr; 16(4):265-9. PubMed ID: 16624189
[TBL] [Abstract][Full Text] [Related]
36. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D
Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
38. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
39. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
Liu Y; Yang R
J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
[TBL] [Abstract][Full Text] [Related]
40. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W
Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
